Branding Partnerships Portfolios 
The Dermatology Digest
OCTOBER 28, 2024
The future of dermatology depends on innovative treatments like VTAMA, and Organon’s acquisition of Dermavant allows us to further expand our existing portfolio of established brands and biosimilar dermatology treatments,” says Kevin Ali, Chief Executive Officer of Organon, in a news release.
Spa Executive
NOVEMBER 10, 2023
As global vice president of wellbeing, she will develop and deepen the wellness experience across Auberge Resorts Collection’s portfolio. We asked Vivianne Garcia-Tunon about her new role, her plans for the Auberge wellbeing brand, and what makes the best wellness experiences.
Spa Executive
JULY 17, 2024
Catherine Warren is Vice President of Strategic Partnerships at Arch Amenities Group, a provider of comprehensive amenity management and consulting services for hotels, residential complexes, and commercial real estate. Revenue generation, programming, public relations, training, and luxury guest service are my passions,” she says.
The Dermatology Digest
SEPTEMBER 9, 2024
“China has always been a strategic market for Sisram, and the approval of Daxxify serves as a key milestone for bringing Sisram’s high-end injectables portfolio to Mainland China,” says Mr. Liu Yi, Sisram Chairman and Executive Director, in a news release.
Spa Executive
JANUARY 16, 2024
The Group recently created the brand new role to solidify a renewed focus on wellness. During the last two decades she was based in southeast Asia, first with Hyatt International Hotels & Resorts and then with Rosewood Hotel Group – where she was responsible for the strategic development of wellness and brand experience.
Spa Executive
OCTOBER 23, 2024
These findings highlight new opportunities for us to innovate across our global portfolio and further enhance guests’ stays. While all Hilton brands offer unique and exclusive bedding, Canopy by Hilton offers a gel memory foam mattress and Serta Cool Balance® technology, with the brand’s signature canopy frame.
The Dermatology Digest
DECEMBER 21, 2023
and Europe of four unique dermal fillers in late-stage development with anticipated regulatory clearances in the second half of 2024 and commercialization under the brand name Estyme (pronounced “esteem”) fillers in 2025. We are extremely excited to expand our partnership with Evolus beyond the U.S. Evolus, Inc. to now include the U.K.
Expert insights. Personalized for you.
36 
Let's personalize your content